Ha habido 50 transacciones internas recientes registradas para Verve Therapeutics, Inc. (VERV), incluyendo 29 compras y 18 ventas. El total de compras internas fue valorado en $9.37M y el total de ventas internas en $1.35M.
Internos destacados con actividad reciente incluyen Adelman Burt A, Maclean Michael F, Yeshwant Krishna. Las transacciones internas pueden proporcionar información sobre cómo la dirección de la empresa ve la valoración y perspectivas futuras de la acción.
Operaciones de Insiders — VERV
| Fecha |
Nombre |
Cargo |
Tipo de Transacción |
Acciones |
Precio Promedio |
Valor |
Acciones en Propiedad |
| 2025-06-05 |
Adelman Burt A |
Director |
Concesión de RSU |
42,200 |
$5.73 |
$241.81K |
42,200 |
| 2025-06-05 |
Maclean Michael F |
Director |
Concesión de RSU |
42,200 |
$5.73 |
$241.81K |
42,200 |
| 2025-06-05 |
Yeshwant Krishna |
10 Percent Owner |
Concesión de RSU |
42,200 |
$5.73 |
$241.81K |
42,200 |
| 2025-06-05 |
Coats Lonnel |
Director |
Concesión de RSU |
42,200 |
$5.73 |
$241.81K |
42,200 |
| 2025-06-05 |
Morrison Jodie Pope |
Director |
Concesión de RSU |
42,200 |
$5.73 |
$241.81K |
42,200 |
| 2025-06-05 |
Cumbo Alexander |
Director |
Concesión de RSU |
42,200 |
$5.73 |
$241.81K |
42,200 |
| 2025-06-05 |
Tatsis Ourania |
Director |
Concesión de RSU |
42,200 |
$5.73 |
$241.81K |
42,200 |
| 2025-06-05 |
Mikhail Sheila |
Director |
Concesión de RSU |
42,200 |
$5.73 |
$241.81K |
42,200 |
| 2025-04-02 |
Ashe Andrew D. |
See Remarks |
Venta Informativa |
2,681 |
$4.15 |
$11.13K |
348,828 |
| 2025-04-02 |
Dorval Allison |
Chief Financial Officer |
Venta Informativa |
3,350 |
$4.15 |
$13.9K |
13,280 |
| 2025-04-02 |
Kathiresan Sekar |
Chief Executive Officer |
Venta Informativa |
9,822 |
$4.15 |
$40.76K |
346,686 |
| 2025-04-02 |
Nickerson Joan |
Chief Administrative Officer |
Venta Informativa |
2,777 |
$4.15 |
$11.52K |
17,420 |
| 2025-04-02 |
Lister Troy |
Chief Scientific Officer |
Venta Informativa |
2,189 |
$4.15 |
$9.08K |
6,952 |
| 2025-04-02 |
Politi Jason |
Chief Technical Ops. Off. |
Venta Informativa |
3,235 |
$4.15 |
$13.43K |
14,226 |
| 2025-04-01 |
Ashe Andrew D. |
See Remarks |
Ejercicio de Opciones (Venta) |
9,000 |
- |
- |
27,000 |
| 2025-04-01 |
Dorval Allison |
Chief Financial Officer |
Ejercicio de Opciones |
11,250 |
- |
- |
16,630 |
| 2025-04-01 |
Kathiresan Sekar |
Chief Executive Officer |
Ejercicio de Opciones (Venta) |
33,000 |
- |
- |
99,000 |
| 2025-04-01 |
Nickerson Joan |
Chief Administrative Officer |
Ejercicio de Opciones (Venta) |
3,315 |
- |
- |
6,630 |
| 2025-04-01 |
Lister Troy |
Chief Scientific Officer |
Ejercicio de Opciones (Venta) |
3,315 |
- |
- |
6,630 |
| 2025-04-01 |
Politi Jason |
Chief Technical Ops. Off. |
Ejercicio de Opciones (Venta) |
3,315 |
- |
- |
6,630 |
| 2025-01-08 |
Ashe Andrew D. |
See Remarks |
Concesión de RSU |
40,000 |
- |
- |
40,000 |
| 2025-01-08 |
Dorval Allison |
Chief Financial Officer |
Concesión de RSU |
45,000 |
- |
- |
45,000 |
| 2025-01-08 |
Kathiresan Sekar |
Chief Executive Officer |
Concesión de RSU |
120,000 |
- |
- |
120,000 |
| 2025-01-08 |
Nickerson Joan |
Chief Administrative Officer |
Concesión de RSU |
40,000 |
- |
- |
40,000 |
| 2025-01-08 |
Lister Troy |
Chief Scientific Officer |
Concesión de RSU |
40,000 |
- |
- |
40,000 |
| 2025-01-08 |
Politi Jason |
Chief Technical Ops. Off. |
Concesión de RSU |
40,000 |
- |
- |
40,000 |
| 2024-12-04 |
Kathiresan Sekar |
Chief Executive Officer |
Donación (Recibida) |
30,000 |
- |
- |
110,997 |
| 2024-12-02 |
Dorval Allison |
Chief Financial Officer |
Venta Informativa |
555 |
$5.64 |
$3.13K |
5,380 |
| 2024-11-29 |
Dorval Allison |
Chief Financial Officer |
Ejercicio de Opciones (Venta) |
1,875 |
- |
- |
1,875 |
| 2024-06-28 |
Kathiresan Sekar |
Chief Executive Officer |
Ejercicio de Opciones (Venta) |
30,000 |
$2.87 |
$86.1K |
215,308 |
| 2024-06-26 |
Adelman Burt A |
Director |
Concesión de RSU |
136,139 |
$5.02 |
$683.42K |
136,139 |
| 2024-06-26 |
Maclean Michael F |
Director |
Concesión de RSU |
136,139 |
$5.02 |
$683.42K |
136,139 |
| 2024-06-26 |
Yeshwant Krishna |
10 Percent Owner |
Concesión de RSU |
136,139 |
$5.02 |
$683.42K |
136,139 |
| 2024-06-26 |
Coats Lonnel |
Director |
Concesión de RSU |
136,139 |
$5.02 |
$683.42K |
136,139 |
| 2024-06-26 |
Morrison Jodie Pope |
Officer |
Desconocido |
- |
- |
- |
- |
| 2024-06-26 |
Morrison Jodie Pope |
Director |
Concesión de RSU |
267,541 |
$5.02 |
$1.34M |
267,541 |
| 2024-06-26 |
Cumbo Alexander |
Director |
Concesión de RSU |
136,139 |
$5.02 |
$683.42K |
136,139 |
| 2024-06-26 |
Tatsis Ourania |
Officer |
Desconocido |
- |
- |
- |
- |
| 2024-06-26 |
Tatsis Ourania |
Director |
Concesión de RSU |
267,541 |
$5.02 |
$1.34M |
267,541 |
| 2024-06-26 |
Mikhail Sheila |
Director |
Concesión de RSU |
136,139 |
$5.02 |
$683.42K |
136,139 |
| 2024-06-26 |
Politi Jason |
Chief Technical Ops. Off. |
Disposición |
90,000 |
$12.75 |
$1.15M |
- |
| 2024-06-21 |
Lister Troy |
Chief Scientific Officer |
Disposición |
16,100 |
- |
- |
- |
| 2024-06-21 |
Lister Troy |
Chief Scientific Officer |
Concesión de RSU |
32,000 |
$5.29 |
$169.28K |
32,000 |
| 2024-05-14 |
Ashe Andrew D. |
See Remarks |
Compra Informativa |
76,000 |
$6.26 |
$475.76K |
342,509 |
| 2024-04-02 |
Nickerson Joan |
Chief Administrative Officer |
Venta Informativa |
1,514 |
$8.24 |
$12.48K |
8,659 |
| 2024-04-01 |
Nickerson Joan |
Chief Administrative Officer |
Ejercicio de Opciones (Venta) |
3,315 |
- |
- |
9,945 |
| 2024-02-14 |
Ashe Andrew D. |
See Remarks |
Concesión de RSU |
36,000 |
- |
- |
36,000 |
| 2024-02-14 |
Dorval Allison |
Chief Financial Officer |
Concesión de RSU |
45,000 |
- |
- |
45,000 |
| 2024-02-14 |
Fiedorek Fred T. |
Chief Medical Officer |
Concesión de RSU |
22,000 |
- |
- |
22,000 |
| 2024-02-14 |
Kathiresan Sekar |
Chief Executive Officer |
Concesión de RSU |
132,000 |
- |
- |
132,000 |
■ Informativa — transacción en mercado abierto (más significativa)
■ No informativa (compra) — premio, ejercicio de opción, conversión
■ No informativa (venta) — retención fiscal, venta de adjudicación
■ Neutral — regalo, fideicomiso, vencimiento
